Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Wegovy: New clinical trial says this weight-loss medication sheds more pounds This story was originally featured on Fortune.com
Source: Jastreboff et al., NEJM 2023 TRIUMPH-4 Phase 3 (68 weeks, 445 participants) Phase 2 Type 2 Diabetes Trial (36 weeks, 281 participants) In the type 2 diabetes population, weight loss was lower than in the obesity trial which is consistent with the pattern seen across all GLP-1 drugs
Tirzepatide raised the ceiling
Some people think that GLP-1 medications are taking the easy way out of fitness plans, but these medications exist for a reason and they can be effective when combined with resistance training and proper nutrition
Order it from them here
They still work somewhat even after long-term use
